This week, John Green continues to teach you about Margaret Atwood's speculative fiction, The Handmaid's Tale. In this installment, we're looking at Atwood's desire to tell a story from a female point of view, and what exactly it means...

Margaret Atwood's speculative fiction masterpiece The Handmaid's Tale explores the consequences of complacency and how power can be wielded unfairly. Atwood's chilling vision of a dystopian regime has captured readers' imaginations since...

As the coronavirus and COVID19 pandemic continues, researchers are investigating some older drugs that may be viable treatments for the disease. One drug of interest is remdesivir, a decade old drug intended to treat hepatitis. It was...

Trials Underway for Coronavirus Treatments & Vaccines: Are We Getting Close? - TLDR News

Gilead’s remdesivir is an antiviral nucleoside analogue that disrupts a virus’s ability to replicate its genome.

Gilead shares are popping on news that its antiviral drug, Remdesevir, cut coronavirus recovery time by five days. It also happens to be one drug allegedly administered to President Trump for his case of the illness. Shares for Zoom are...

Purchase of some 500,000 treatment courses practically means no other country can buy drug for next three months.

Gilead Science reportedly turned down an offer of a merger with AstraZeneca worth $232 billion. AstraZeneca is the UK's largest drugmaker.

According to STAT News, a hospital in Chicago treating COVID-19 patients with an antiviral treatment created by Gilead Sciences has seen them quickly recover from fevers and respiratory issues. It has even been able to discharge patients...

Researchers say Remdesivir, a drug designed to treat Ebola, is showing promising results against COVID-19 but warn it’s too soon to say.

The Department of Health and Human Services says Gilead Sciences is profiting off HIV prevention drugs patented by the U.S. government.

A combination of the antiviral remdesivir and an 80-year-old anti-malaria drug could treat coronavirus patients.

The company plans to start screening healthy volunteers for phase one trials this week and hopes to begin studies in August.

The FDA approved emergency use its anti-viral drug for further testing on those with severe cases requiring them to be on breathing support.

Drugmaker Gilead will start testing an inhalable version of remdesivir. The FDA is warning against the use of methanol-based hand sanitizers.

Aug.28 -- Bloomberg’s Taylor Riggs discusses a Gilead Sciences-Kite Pharma deal. She speaks with Bloomberg's Vonnie Quinn on "Bloomberg Markets."

Supreme Court will hear arguments involving the ACA and contraception. Gilead to increase production of remdesivir to ensure global supply.

Jun.30 -- China put 400,000 residents of a northern county under lockdown over the weekend after at least a dozen coronavirus cases associated with the Beijing outbreak were reported there. Bloomberg's Selina Wang has the story.

An official from the Department of Health and Human Services says the last shipment of the COVID-19 treatment drug will be sent the week of June 29.

Patients given remdesivir for five days had improved symptoms compared to those who were only given standard care.

Brian Abrahams, RBC Capital Markets co-head of biotechnology research, discusses his call for the performance of Gilead Sciences's��experimental coronavirus therapy on "Bloomberg Markets: The Close." (Source: Bloomberg)

Jun.07 -- AstraZeneca Plc has made a preliminary approach to rival drugmaker Gilead Sciences Inc. about a potential merger, according to people familiar with the matter. Su Keenan reports on "Bloomberg Daybreak: Australia."

Gilead will start enrolling COVID-19 pediatric patients in a late-stage remdesivir study. California issues a statewide face mask order.

Gilead Sciences will increase production of the drug remdesivir. New York will hire 17,000 contact tracers to track people infected with COVID-19.